Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014-2015 influenza season in Alberta, Canada

被引：11

作者：

Chaudhry, Ahsan ^{[1
,2
]}

Bastien, Nathalie ^{[3
]}

Li, Yan ^{[3
]}

Scott, Allison ^{[4
]}

Pabbaraju, Kanti ^{[5
]}

Stewart, Douglas ^{[1
,2
]}

Wong, Sallene ^{[5
]}

Drews, Steven J. ^{[6
,7
]}

机构：

[1] Univ Calgary, Dept Oncol, Calgary, AB, Canada

[2] Univ Calgary, Dept Med, Calgary, AB, Canada

[3] Natl Microbiol Lab, Winnipeg, MB, Canada

[4] Surveillance & Assessment Accountabil & Performan, Edmonton, AB, Canada

[5] ProvLab Alberta Calgary, Calgary, AB, Canada

[6] ProvLab Alberta Edmonton, Edmonton, AB, Canada

[7] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada

来源：

INFLUENZA AND OTHER RESPIRATORY VIRUSES | 2016年 / 10卷 / 06期

关键词：

H3N2; influenza; neuraminidase inhibitors; reduced susceptibility; resistance; sequence analysis; NEURAMINIDASE INHIBITORS; SUSCEPTIBILITY; ASSAYS;

D O I：

10.1111/irv.12415

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

This manuscript describes the identification of an oseltamivir-resistant influenza A (H3N2) virus in a respiratory specimen collected from an immunocompromised patient in Alberta, Canada, during the 2014-2015 influenza season. Following treatment with oseltamivir, neuraminidase (NA) gene sequencing indicated the presence of an R292K mutation. Phenotypic susceptibility testing by the NA-Star assay indicated a highly reduced inhibition by oseltamivir and normal inhibition by zanamivir. The use of zanamivir following identification of the oseltamivir-resistant strain, combined with a partial immune reconstitution, was followed by a suggested decrease in the nasopharyngeal viral load in the nasopharynx and clinical improvement of the patient.

引用

页码：532 / 535

页数：4

共 50 条

[41] First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection [J].

Campanini, Giulia ;

Piralla, Antonio ;

Rovida, Francesca ;

Puzelli, Simona ;

Facchini, Marzia ;

Locatelli, Franco ;

Minoli, Lorenzo ;

Percivalle, Elena ;

Donatelli, Isabella ;

Baldanti, Fausto .

JOURNAL OF CLINICAL VIROLOGY, 2010, 48 (03) :220-222

[42] Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1) pdm09 viruses [J].

Pizzorno, Andres ;

Abed, Yacine ;

Rheaume, Chantal ;

Boivin, Guy .

ANTIVIRAL RESEARCH, 2014, 105 :54-58

[43] Evolution and rapid spread of a reassortant A(H3N2) virus that predominated the 2017-2018 influenza season [J].

Potter, Barney I. ;

Kondor, Rebecca ;

Hadfield, James ;

Huddleston, John ;

Barnes, John ;

Rowe, Thomas ;

Guo, Lizheng ;

Xu, Xiyan ;

Neher, Richard A. ;

Bedford, Trevor ;

Wentworth, David E. .

VIRUS EVOLUTION, 2019, 5 (02)

[44] Detection of a Transient R292K Mutation in Influenza A/H3N2 Viruses Shed for Several Weeks by an Immunocompromised Patient [J].

Babady, N. Esther ;

Laplante, Jennifer M. ;

Tang, Yi-Wei ;

St George, Kirsten .

JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (04) :1415-1418

[45] Whole-genome sequences of two influenza A (H3N2) virus strains isolated from Qinghai, China [J].

Yu, Juan ;

Zhao, Shengcang ;

Rao, Huaxiang .

BIOSAFETY AND HEALTH, 2021, 3 (02) :81-86

[46] Characterization of a Large Cluster of Influenza A(H1N1)pdm09 Viruses Cross-Resistant to Oseltamivir and Peramivir during the 2013-2014 Influenza Season in Japan [J].

Takashita, Emi ;

Kiso, Maki ;

Fujisaki, Seiichiro ;

Yokoyama, Masaru ;

Nakamura, Kazuya ;

Shirakura, Masayuki ;

Sato, Hironori ;

Odagiri, Takato ;

Kawaoka, Yoshihiro ;

Tashiro, Masato .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (05) :2607-2617

[47] Infections with Influenza A/H3N2/Subtype in Poland in the 2016/2017 Epidemic Season [J].

Szymanski, K. ;

Kowalczyk, D. ;

Cieslak, K. ;

Hallmann-Szelinska, E. ;

Brydak, L. B. .

CURRENT TRENDS IN IMMUNITY AND RESPIRATORY INFECTIONS, 2018, 1108 :93-98

[48] Clinical effectiveness of neuraminidase inhibitors-oseltamivir, zanamivir, laninamivir, and peramivir-for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan [J].

Shobugawa, Yugo ;

Saito, Reiko ;

Sato, Isamu ;

Kawashima, Takashi ;

Dapat, Clyde ;

Dapat, Isolde Caperig ;

Kondo, Hiroki ;

Suzuki, Yasushi ;

Saito, Kousuke ;

Suzuki, Hiroshi .

JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) :858-864

[49] Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999 [J].

Bauer, Katja ;

Schrader, Christina ;

Suess, Jochen ;

Wutzler, Peter ;

Schmidtke, Michaela .

ANTIVIRAL RESEARCH, 2007, 75 (03) :219-226

[50] Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice [J].

Smee, Donald F. ;

Barnard, Dale L. ;

Jones, Steven M. .

ANTIVIRAL RESEARCH, 2016, 136 :45-50

← 1 2 3 4 5 →